首页> 外文期刊>World Journal of Gastroenterology >Hepatitis B virus reactivation in a patient undergoing steroid-free chemotherapy
【24h】

Hepatitis B virus reactivation in a patient undergoing steroid-free chemotherapy

机译:接受无类固醇化疗的患者的乙肝病毒再激活

获取原文
获取原文并翻译 | 示例
           

摘要

A 62-year-old Japanese man who was positive for hepatitis B surface antigen (HBsAg) and anti-HBe antibody, underwent chemotherapy for non-Hodgkin's lymphoma (NHL). Mutations were detected in the precore region (nt1896) of HBV. Because steroid-containing regimen may cause reactivation of hepatitis B virus (HBV) and hepatitis may progress to be fulminant after its withdrawal, we administered CHO (CPA, DOX and VCR) therapy and the patient obtained complete response. However, he developed acute exacerbation of hepatitis due to HBV reactivation. Recovery was achieved with lamivudine (100 mg/d) and plasma exchange. The present case suggests that acute exacerbation of hepatitis can occur with steroid-free regimen. Because the efficacy of the prophylactic use of lamivudine has been reported and the steroid enhances curability of malignant lymphoma, the steroid containing regimen with prophylaxis of lamivudine should be evaluated further.
机译:一名62岁的日本人,他对乙肝表面抗原(HBsAg)和抗HBe抗体呈阳性,接受了非霍奇金淋巴瘤(NHL)化疗。在HBV前核区(nt1896)中检测到突变。由于含类固醇疗法可能会导致乙型肝炎病毒(HBV)的再激活,并且在停药后肝炎可能会逐渐暴发,因此我们进行了CHO(CPA,DOX和VCR)治疗,患者获得了完全缓解。但是,由于HBV激活,他患上了急性肝炎。拉米夫定(100 mg / d)和血浆置换可实现恢复。本病例表明,无类固醇疗法可导致肝炎急性加重。因为已经报道了预防性使用拉米夫定的功效,并且类固醇增强了恶性淋巴瘤的可治愈性,所以应进一步评估含类固醇的拉米夫定的预防方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号